home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410b.zip
/
M94A0253.TXT
< prev
next >
Wrap
Text File
|
1994-10-08
|
3KB
|
43 lines
Document 0253
DOCN M94A0253
TI Hepatitis C experience at a community teaching hospital.
DT 9412
AU Woodall DW; Godenick M; Valainis GT; Department of Medical Education,
Spartanburg Regional Medical; Center, SC.
SO J Fam Pract. 1994 Sep;39(3):257-61. Unique Identifier : AIDSLINE
MED/94358701
AB BACKGROUND. The purpose of this study was to review the initial
serologic testing experience for hepatitis C (HCV) and physician
response at a community teaching hospital. METHODS. A retrospective
chart review was performed for the 59 (5%) HCV-positive patients of 1244
patients who were tested by means of a new enzyme immunosorbent assay
(EIA) for HCV antibodies between October 28, 1990, and October 27, 1991.
RESULTS: Physicians identified HCV risk factors, including intravenous
drug use (n = 14, 25%) and having received blood products (n = 15, 27%).
One half of the patients were not queried about the known risk factors
for HCV. The most common reason for ordering an HCV assay was elevated
liver enzymes. None of the patients underwent supplementary HCV testing
(ie, polymerase chain reaction or recombinant immunoblot assay). In 23
(40%) of the HCV-positive patients, no action was taken by the
physician, and 15 (27%) were lost to follow-up. The remaining 18
patients (33%) had further follow-up with laboratory or treatment.
CONCLUSIONS. These results indicate the need for increased physician
awareness of risk factors for HCV and improved documentation of these
factors in taking patient history. In addition, primary care physicians
need to be educated about new laboratory tests and how to interpret test
results and when to order supplemental testing.
DE Adolescence Adult Aged Aged, 80 and over Alanine
Aminotransferase/BLOOD Comparative Study Evaluation Studies Female
Hepatitis Antibodies/ANALYSIS Hepatitis
C/COMPLICATIONS/*DIAGNOSIS/IMMUNOLOGY Hepatitis C Viruses/IMMUNOLOGY
Hospital Bed Capacity, 500 and over Hospitals, Community/STATISTICS &
NUMER DATA/*STANDARDS Hospitals, Teaching/STATISTICS & NUMER
DATA/*STANDARDS Human HIV Seropositivity/COMPLICATIONS Immunoenzyme
Techniques Male *Medical Audit Middle Age Retrospective Studies
Risk Factors Substance Abuse, Intravenous Support, Non-U.S. Gov't
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).